Cargando…
Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520084/ http://dx.doi.org/10.1007/s40278-021-03819-9 |
Ejemplares similares
-
Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022) -
Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020) -
Enoxaparin sodium/methylprednisolone: Cytomegalovirus reactivation, gastrointestinal haemorrhage and off-label use: case report
Publicado: (2020) -
Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021) -
Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)